Section Arrow
Quote
TOI.NASDAQ
- Oncology Institute (The)
Quotes are at least 15-min delayed:2025/07/05 21:36 EDT
Last
 2.52
+0.08 (+3.28%)
Day High 
2.5391 
Prev. Close
2.44 
1-M High
3.27 
Volume 
813.01K 
Bid
2.45
Ask
2.51
Day Low
2.4 
Open
2.45 
1-M Low
2.015 
Market Cap 
224.27M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.27 
20-SMA 2.47 
50-SMA 2.72 
52-W High 3.5 
52-W Low 0.1253 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.70/--
Enterprise Value
340.62M
Balance Sheet
Book Value Per Share
0.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
393.41M
Operating Revenue Per Share
3.19
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AGLagilon health2.43+0.04+1.67%-- 
BKDBrookdale Senior Living6.84-0.04-0.58%-- 
ACHCAcadia Healthcare Company23.36+0.17+0.73%11.21PE
LFSTLifeStance Health Group4.79+0.015+0.31%-- 
CMPSCOMPASS Pathways Plc3.26-0.12-3.55%-- 
Quotes are at least 15-min delayed：2025/07/05 21:36 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.